Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...

The approval of a new drug that can slow the progress of Alzheimer’s disease is being hailed as a historic moment in the ...

The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...

Scientists do not fully understand what causes the chronic neurodegenerative disease Alzheimer's, but they are examining a ...

Having lower cholesterol levels may help protect against dementia, according to a large-scale international study led by the ...